Gene Therapy - Table of Contents alert Volume 20 Issue 4

TABLE OF CONTENTS Volume 20, Issue 4 (April 2013) In this issue Enabling Technologies Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Free for everyone: Clinical Utility Gene Cards Bringing together information regarding a specific disease and providing clinicians with guidance on genetic testing for hereditary conditions in real settings of clinical genetic services. Read the series on EJHG website for FREE.   Enabling Technologies Top Bioprocess development for canine adenovirus type 2 vectors P Fernandes, C Peixoto, V M Santiago, E J Kremer, A S Coroadinha and P M Alves Gene Ther 2013 20: 353-360; advance online publication, July 5, 2012; 10.1038/gt.2012.52 Abstract | Full Text Original Articles Top Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, K Tremblay, J de Wal, J Twisk, N van den Bulk, V Sier-Ferreira and S van Deventer Gene Ther 2013 20: 361-369; advance online publication, June 21, 2012; 10.1038/gt.2012.43 Abstract | Full Text BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells O Mizrahi, D Sheyn, W Tawackoli, I Kallai, A Oh, S Su, X Da, P Zarrini, G Cook-Wiens, D Gazit and Z Gazit Gene Ther 2013 20: 370-377; advance online publication, June 21, 2012; 10.1038/gt.2012.45 Abstract | Full Text Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes H S Kim and H S Yoo Gene Ther 2013 20: 378-385; advance online publication, June 21, 2012; 10.1038/gt.2012.49 Abstract | Full Text Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma P C Schuberth, G Jakka, S M Jensen, A Wadle, F Gautschi, D Haley, S Haile, A Mischo, G Held, M Thiel, M Tinguely, C B Bifulco, B A Fox, C Renner and U Petrausch Gene Ther 2013 20: 386-395; advance online publication, June 28, 2012; 10.1038/gt.2012.48 Abstract | Full Text SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery L Lipskaia, L Hadri, P Le Prince, B Esposito, F Atassi, L Liang, M Glorian, I Limon, A-M Lompre, S Lehoux and R J Hajjar Gene Ther 2013 20: 396-406; advance online publication, July 5, 2012; 10.1038/gt.2012.50 Abstract | Full Text High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression K Kizzire, S Khargharia and K G Rice Gene Ther 2013 20: 407-416; advance online publication, July 12, 2012; 10.1038/gt.2012.47 Abstract | Full Text Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue Open F Mingozzi, Y Chen, S C Edmonson, S Zhou, R M Thurlings, P P Tak, K A High and M J Vervoordeldonk Gene Ther 2013 20: 417-424; advance online publication, July 12, 2012; 10.1038/gt.2012.55 Abstract | Full Text Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa D L Greenwald, S M Cashman and R Kumar-Singh Gene Ther 2013 20: 425-434; advance online publication, July 19, 2012; 10.1038/gt.2012.53 Abstract | Full Text Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53 A Reschner, S Bontems, S Le Gac, J Lambermont, L Marcélis, E Defrancq, P Hubert, C Moucheron, A Kirsch-De Mesmaeker, M Raes, J Piette and P Delvenne Gene Ther 2013 20: 435-443; advance online publication, July 19, 2012; 10.1038/gt.2012.54 Abstract | Full Text Oncolytic measles virus strains have significant antitumor activity against glioma stem cells C Allen, M Opyrchal, I Aderca, M A Schroeder, J N Sarkaria, E Domingo, M J Federspiel and E Galanis Gene Ther 2013 20: 444-449; advance online publication, August 23, 2012; 10.1038/gt.2012.62 Abstract | Full Text Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates S J Gray, S Nagabhushan Kalburgi, T J McCown and R Jude Samulski Gene Ther 2013 20: 450-459; advance online publication, January 10, 2013; 10.1038/gt.2012.101 Abstract | Full Text Short Communication Top Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes A P Dane, S J Wowro, S C Cunningham and I E Alexander Gene Ther 2013 20: 460-464; advance online publication, August 16, 2012; 10.1038/gt.2012.67 Abstract | Full Text Corrigendum Top Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates S J Gray, S Nagabhushan Kalburgi, T J McCown and R Jude Samulski Gene Ther 2013 20: 465; 10.1038/gt.2013.11 Full Text Advertisement Clinical & Translational Immunology (CTI) Now Live - a new open access online-only journal covering basic, translational and clinical studies in all aspects of human immunology, including experimental models specific to human diseases. Discover more about CTI   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.